ABBOTT Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ABBOTT, and what generic and branded alternatives to ABBOTT drugs are available?
ABBOTT has one hundred and eleven approved drugs.
Drugs and US Patents for ABBOTT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | METRONIDAZOLE | metronidazole | INJECTABLE;INJECTION | 018889-001 | Nov 18, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | PEDIATRIC LTA KIT | lidocaine hydrochloride | SOLUTION;TOPICAL | 088572-001 | Jul 31, 1984 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | ENFLURANE | enflurane | LIQUID;INHALATION | 070803-001 | Sep 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Abbott | PROMETHAZINE HYDROCHLORIDE | promethazine hydrochloride | INJECTABLE;INJECTION | 084222-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ABBOTT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-003 | Aug 7, 1987 | 4,112,097 | ⤷ Sign Up |
Abbott | DEPAKOTE CP | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 019794-002 | Jul 11, 1990 | 5,212,326*PED | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | TABLET;ORAL | 019057-002 | Aug 7, 1987 | 5,412,095 | ⤷ Sign Up |
Abbott | HYTRIN | terazosin hydrochloride | CAPSULE;ORAL | 020347-004 | Dec 14, 1994 | 4,251,532 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ABBOTT drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 100 mg | ➤ Subscribe | 2012-10-31 |
➤ Subscribe | Tablets | 100 mg | ➤ Subscribe | 2010-12-21 |
➤ Subscribe | Capsules | 10 mg and 15 mg | ➤ Subscribe | 2009-08-14 |
Similar Applicant Names
Here is a list of applicants with similar names.